Andrew L. Coveler

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer”.

MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer

Radiology(2024)10.1148/radiol.232748

N/A

0.665DataRank · unranked

21 citations

Dana M. Omer, H Thompson, Sabrina T. Lin, Floris S. Verheij, João Miranda +56 more

Survival and organ preservation according to clinical response after total neoadjuvant therapy in locally advanced rectal cancer patients: A secondary analysis from the organ preservation in rectal adenocarcinoma (OPRA) trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3509

N/A

0.533DataRank · unranked

34 citations

Jin Ki Kim, Jonathan B. Yuval, Floris S. Verheij, Sujata Patil, Marc J. Gollub +15 more

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008436

N/A

0.396DataRank · unranked

13 citations

Harshabad Singh, Lestat R. Ali, Nora Horick, S. Jennifer Wang, Megan T. Hoffman +33 more

Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.09.019

N/A

0.113DataRank · unranked

1 citations

Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, William R. Gwin, Jessica Reichow, Yushe Dang +7 more

Homologous recombination deficiency (HRD) by BROCA-HR and survival outcomes after surgery for patients (pts) with pancreatic adenocarcinoma (PC): A single institution experience.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.732

N/A

0.104DataRank · unranked

1 citations

David B. Zhen, Marc R. Radke, Kelsey K. Baker, Andrew L. Coveler, Kit Man Wong +5 more

A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer

Vaccines(2025)10.3390/vaccines13020117

N/A

0DataRank · unranked

5 citations

Lupe G. Salazar, James Y. Dai, Doreen M. Higgins, Andrew L. Coveler, Jennifer S. Childs +7 more

Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1579

N/A

0DataRank · unranked

20 citations

John B. Liao, Yushe Dang, Andrew L. Coveler, Angela Shaulov Kask, Yi Yang +4 more

Final report and long-term outcomes: Phase I trial of a HER2 intracellular plasmid-based vaccine in HER2+ advanced stage breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2619

N/A

0DataRank · unranked

7 citations

Yushe Dang, Andrew L. Coveler, Doreen M. Higgins, Jennifer S. Childs, Lupe G. Salazar +1 more

Data from Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses

(2023)10.1158/1078-0432.c.6531173

N/A

0DataRank · unranked

0 citations

John B. Liao, Yushe Dang, Andrew L. Coveler, Angela Shaulov Kask, Yi Yang +4 more